1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Channelopathies: new trials by email Literature Review of Channelopathies trials Research Report on Channelopathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mutation-specific Therapy for the Long QT Syndrome Lumacaftor / Ivacaftor, Orkambi® Oral Tablet - Long QT Syndrome | Phase 2 | Completed | Istituto Auxologico Italiano | 16 | 2021-06-15 | 2025-04-25 |
Death, Sudden, Cardiac (1) · Long QT Syndrome (1)
Arrhythmias, Cardiac (1) · Cardiac Conduction System Disease (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Death (1) · Death, Sudden (1) · Heart Arrest (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
ivacaftor (1) · lumacaftor (1) · lumacaftor, ivacaftor drug combination (1)
Istituto Auxologico Italiano (1)
Italy (1)
Lia Crotti, MD (1) · Peter J Schwartz, MD (1)